LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Operating Expenses | 11,449 | 8,657 | 7,210 | 5,981 | 6,960 |
| Operating Income | -11,449 | -8,657 | -7,210 | -5,981 | -6,960 |
| Interest Expense | 9 | 6 | 10 | 10 | 10 |
| Other Income | 100 | 548 | 520 | 645 | 870 |
| Pre-tax Income | -11,358 | -8,115 | -6,700 | -5,346 | -6,100 |
| Net Income Continuous | -11,358 | -8,115 | -6,682 | -5,346 | -6,106 |
| Net Income | $-11,358 | $-8,115 | $-6,682 | $-5,346 | $-6,106 |
| EPS Basic Total Ops | -0.27 | -0.20 | -475,000.00 | -0.15 | -425,000.10 |
| EPS Basic Continuous Ops | -0.27 | -0.20 | -475,000.00 | -0.15 | -425,000.10 |
| EPS Diluted Total Ops | -0.27 | -0.20 | -475,000.00 | -0.15 | -425,000.10 |
| EPS Diluted Continuous Ops | -0.27 | -0.20 | -475,000.00 | -0.15 | -425,000.10 |
| EBITDA(a) | $-10,835 | $-8,163 | $-7,135 | $-5,981 | $-6,780 |